-
Blocking Brain Inflammation Molecule May Halt Alzheimer’s
Medical Mythbusting Commentary for June 4, 2025 Source: Blocking Brain Inflammation Molecule May Halt Alzheimer’s Reference: STING deletion protects against amyloid β–induced Alzheimer’s disease pathogenesis
-
A challenge to the hypothesis explaining the pathophysiology of Alzheimer’s Disease.
Medical Mythbusting Commentary for December 11, 2024 Source:Neuroscientists just turned a major Alzheimer’s theory on its head Reference:Increases in amyloid-β42 slow cognitive and clinical decline in Alzheimer’s disease trials
-
For the first time, researchers have identified a genetic form of late-in-life Alzheimer’s disease
Medical Mythbusting Commentary for May 8, 2024 Source:For the first time, researchers have identified a genetic form of late-in-life Alzheimer’s disease
-
Rare cases of possible Alzheimer’s transmission uncovered in recipients of discontinued cadaver-based growth hormone treatments
Medical Mythbusting Commentary for January 31, 2024 Source:Rare cases of possible Alzheimer’s transmission uncovered in recipients of discontinued medical treatment Reference:Iatrogenic Alzheimer’s disease in recipients of cadaveric pituitary-derived growth hormone
-
Time Magazine piece on treatment of early Alzheimer’s Disease lacks balance. It reads as an ad for pharma company that made it. Side effects glossed over and relative instead of absolute risk reported. Clinical outcomes overstated.
Medical Mythbusting Commentary for October 27, 2023 Source:Why Diagnosing Alzheimer’s Early Is So Important Reference:Lecanemab for Alzheimer’s disease: tempering hype and hope
-
New diagnostic test for early Alzheimer’s does not prove that you will develop the disease and requires more biomarkers to ensure accuracy.
Medical Mythbusting Commentary for August 24, 2023 Source:Commercially available Alzheimer’s blood test could help early diagnosis
-
New non-invasive tool can detect early stages of Alzheimer’s and Parkinson’s. However device is in prototype stage with further testing and evaluation to follow.
Medical Mythbusting Commentary for June 5, 2023 Source:New non-invasive tool can detect early stages of Alzheimer’s and Parkinson’s
-
Lilly claims drug slows Alzheimer’s progression by 35 per cent in trial. However there are significant side effects that require our attention respecting the risk vs benefit and long-term outcomes.
Medical Mythbusting Commentary for May 5, 2023 Source:Lilly drug slows Alzheimer’s progression by 35 per cent in trial